ADVERTISEMENT
Hester Biosciences Sees 35% Jump In Domestic Business Next Year
Hester Biosciences also expects 39 percent growth in operating income in the second half of this financial year.
23 Dec 2017, 12:54 PM IST 
Capsules are laid out for inspection on a production line (Photographer: Tomohiro Ohsumi/Bloomberg)
Hester Biosciences Ltd. expects about 35 percent growth in its domestic business in the next financial year, its Managing Director Rajiv Gandhi said.
The company also sees 40 percent growth in operating margins from diagnostics business, he told BloombergQuint in an interview. Gandhi also expects about 39 percent growth in operating income during the second half of the current financial year.
Watch the full interview here: